Table 4

Device Monitoring Times Postimplantation: Health Care Financing Administration 1984 Guidelines for Transtelephonic Monitoring

Postimplantation MilestoneMonitoring Time
Guideline I
 Single chamber
  1st monthEvery 2 weeks
  2nd to 36th monthEvery 8 weeks
  37th month to failureEvery 4 weeks
 Dual chamber
  1st monthEvery 2 weeks
  2nd to 6th monthEvery 4 weeks
  7th to 36th monthEvery 8 weeks
  37th month to failureEvery 4 weeks
Guideline II
 Single chamber
  1st monthEvery 2 weeks
  2nd to 48th monthEvery 12 weeks
  49th month to failureEvery 4 weeks
 Dual chamber
  1st monthEvery 2 weeks
  2nd to 30th monthEvery 12 weeks
  31st to 48th monthEvery 8 weeks
  49th month to failureEvery 4 weeks

Modified from the US Department of Health and Human Services (315). In the public domain.